The pH of chemistry assays plays an important role in monoclonal immunoglobulin interferences

Practical Laboratory Medicine

Volumn 3, Issue , 2015, Pages 8-16

  Alberti, Michael O ^a   Drake, Thomas A ^a   Song, Lu ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Assay conditions; Creatinine; IgM paraprotein; Interference of chemistry assays; Monoclonal protein; PH induced

Indexed keywords

EID: 84945321566     PISSN: None     EISSN: 23525517     Source Type: Journal    
DOI: 10.1016/j.plabm.2015.09.001     Document Type: Article

References (27)

1. Yang Y., Howanitz P.J., Howanitz J.H., Gorfajn H., Wong K. Paraproteins are a common cause of interferences with automated chemistry methods. Arch. Pathol. Lab. Med. 2008, 132:217-223.
2. Song L., Kelly K.A., Butch A.W. Monoclonal and polyclonal immunoglobulin interference in a conjugated bilirubin assay. Arch. Pathol. Lab. Med. 2014, 138:950-954.
3. Reed R.G. Interference by an IgM paraprotein in the bromcresol green method for determination of serum albumin. Clin. Chem. 1987, 33:1075-1076.
4. Dimeski G., Carter A. Rare IgM interference with Roche/Hitachi Modular glucose and gamma-glutamyltransferase methods in heparin samples. Clin. Chem. 2005, 51:2202-2204.
5. Tokmakjian S., Moses G., Haines M. Excessive sample blankings in two analyzers generate reports of apparent hypoglycemia and hypophosphatemia in patients with macroglobulinemia. Clin. Chem. 1990, 36:1261-1262.
6. Yamada K., Yagihashi A., Ishii S., et al. Interference with nephelometric assay of C-reactive protein and antistreptolysin-O by monoclonal IgM-kappa from a myeloma patient. Clin. Chem. 1997, 43:2435-2437.
7. Langman L.J., Allen L.C., Romaschin A.D. Interference of IgM paraproteins in the Olympus AU800 uric acid assay. Clin. Biochem. 1998, 31:517-521.
8. Smogorzewska A., Flood J.G., Long W.H., Dighe A.S. Paraprotein interference in automated chemistry analyzers. Clin. Chem. 2004, 50:1691-1693.
9. Bakker A.J., Zijlstra A., Leemhuis M.P. False negative results in the Roche assay for HDL-cholesterol. Ann. Clin. Biochem. 2003, 40:572-575.
10. Kadri N., Douville P., Lachance P. Monoclonal paraprotein may interfere with the Roche direct HDL-C Plus assay. Clin. Chem. 2002, 48:964.
11. Pantanowitz L., Horowitz G.L., Upalakalin J.N., Beckwith B.A. Artifactual hyperbilirubinemia due to paraprotein interference. Arch. Pathol. Lab. Med. 2003, 127:55-59.
12. Hummel K.M., von Ahsen N., Kuhn R.B., et al. Pseudohypercreatininemia due to positive interference in enzymatic creatinine measurements caused by monoclonal IgM in patients with Waldenstrom macroglobulinemia. Nephron 2000, 86:188-189.
13. Rudofsky G., Villalobos M., Waldherr R., et al. The case: Renal failure in a male with Waldenstrom macroglobulinemia. Kidney Int. 2010, 77:371-372.
14. Storsley L., Fine A., Krahn J. IgM monoclonal protein presenting as pseudohypercreatininaemia. Nephrol. Dial. Transplant. 2006, 21:3337-3338.
15. Kwok J.S., Chow K.M., Lit L.C., Chan M.H. Paraproteinemia-associated pseudohypercreatininemia across different analytical methodologies. Kidney Int. 2010, 78:621-622.
16. Tichy M., Friedecky B., Budina M., et al. Interference of IgM-lambda paraprotein with biuret-type assay for total serum protein quantification. Clin. Chem. Lab. Med. 2009, 47:235-236.
17. Sykes M.O., Harrison S.P. Discrepant serum total protein results for serum from some myeloma patients, as analyzed in the SMAC. Clin. Chem. 1988, 34:1521.
18. Whitlow K.J., Nanji A.A., Pudek M.R. Artefactual decrease in total protein concentration in patients with monoclonal gammopathies: a method-dependent error. Clin. Biochem. 1984, 17:233-235.
19. John R., Oleesky D., Issa B., et al. Pseudohypercalcaemia in two patients with IgM paraproteinaemia. Ann. Clin. Biochem. 1997, 34(Pt 6):694-696.
20. Liddell E. Antibodies. The Immunoassay Handbook 2005, 146. Elsevier Publishing Inc, Amsterdam, Netherlands. third edition. D. Wild (Ed.).
21. Chi E.Y., Krishnan S., Randolph T.W., Carpenter J.F. Physical stability of proteins in aqueous solution: mechanism and driving forces in nonnative protein aggregation. Pharm. Res. 2003, 20:1325-1336.
22. Berth M., Delanghe J. Protein precipitation as a possible important pitfall in the clinical chemistry analysis of blood samples containing monoclonal immunoglobulins: 2 case reports and a review of the literature. Acta Clin. Belg. 2004, 59:263-273.
23. King R.I., Florkowski C.M. How paraproteins can affect laboratory assays: spurious results and biological effects. Pathology 2010, 42:397-401.
24. Bakker A.J., Mucke M. Gammopathy interference in clinical chemistry assays: mechanisms, detection and prevention. Clin. Chem. Lab. Med. 2007, 45:1240-1243.
25. Roy V. Artifactual laboratory abnormalities in patients with paraproteinemia. South. Med. J. 2009, 102:167-170.
26. Dalal B.I., Brigden M.L. Factitious biochemical measurements resulting from hematologic conditions. Am. J. Clin. Pathol. 2009, 131:195-204.
27. Seimiya M., Suzuki Y., Yoshida T., Sawabe Y., Matsushita K., Nomura F. The abnormal reaction data-detecting function of the automated biochemical analyzer was useful to prevent erroneous total-bilirubin measurement and to identify monoclonal proteins. Clin. Chim. Acta 2014, 441c:44-46.